menu
    • menu

    Company profile for Roivant Sciences

    NEW Drugs in Dev: 6
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology. The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, ...
    Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology. The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Roivant SciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    320 West 37th Street 6th Floor New York, NY 10018
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://roivant.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/roivant-sciences-inc-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/roivant?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Roivant Reports Q4 and FY2026 Results and Business Update
    Roivant Reports Q4 and FY2026 Results and Business Update

    20 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/20/3298334/34323/en/roivant-reports-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provides-business-update.html

    GLOBENEWSWIRE
    20 May 2026
    Share Share
    Roivant To Release Q4 2026 Financial Results And Business Update
    Roivant To Release Q4 2026 Financial Results And Business Update

    11 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/11/3292332/34323/en/roivant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may-20-2026.html

    GLOBENEWSWIRE
    11 May 2026
    Share Share
    Roivant’s CEO thinks China is a ‘red herring’
    Roivant’s CEO thinks China is a ‘red herring’

    17 Apr 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/roivants-ceo-thinks-china-red-herring

    FIERCE BIOTECH
    17 Apr 2026
    Share Share
    Roivant Expands Brepocitinib to LPP; Phase 3 Batoclimab Data
    Roivant Expands Brepocitinib to LPP; Phase 3 Batoclimab Data

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267157/34323/en/Roivant-Announces-Expansion-of-Brepocitinib-Development-Program-with-New-Phase-2b-3-Trial-in-Lichen-Planopilaris-LPP-and-Phase-3-Study-Results-for-Batoclimab-in-Thyroid-Eye-Disease.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share
    Roivant Units Reach $2.25B Patent Settlement With Moderna
    Roivant Units Reach $2.25B Patent Settlement With Moderna

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248941/34323/en/Roivant-Announces-Genevant-Sciences-and-Arbutus-Biopharma-s-2-25-Billion-Global-Settlement-With-Moderna.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Roivant Reports Positive Phase 2 Data For Brepocitinib
    Roivant Reports Positive Phase 2 Data For Brepocitinib

    06 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/06/3233728/34323/en/Roivant-Announces-Positive-Phase-2-Results-for-Brepocitinib-in-Cutaneous-Sarcoidosis-CS-and-Reports-Financial-Results-for-the-Third-Quarter-Ended-December-31-2025.html

    GLOBENEWSWIRE
    06 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search